AtrioSciences Request a quotation

How the company operates.

Atrio Sciences treats regulatory boundaries as a design constraint from the first product decision. The practices below apply to the catalogue, to ordering and to dispatch.

HNROHNROHNROHNROHNROHNROHNROHNROHNROHNROHN

Regulatory frame.

Every material is supplied as a research-use-only laboratory reference material for in-vitro research and analytical use. This is a regulatory frame, not a marketing label: materials are not represented, packaged, labelled or sold as medicines, foods, supplements, cosmetics or medical devices.

The company operates within the ordinary EU regulatory perimeter of an EU-domiciled seller of laboratory reference chemicals to EU customers.

EU consumer-protection law
Distance-selling information duties, withdrawal rights and fair-commercial-practice rules.
National medicines legislation
The boundary the research-use frame is built to respect: no representation, claim or use that would bring a material within medicinal-product regulation.
REACH and CLP
Classification, labelling and packaging, and safety data sheets, where applicable.
GDPR
Atrio Sciences is controller of customer data.

A material does not reach the catalogue by default.

  1. 1

    Legal-status screen

    Per-market check against national medicines and controlled-substance status before any listing work begins.

  2. 2

    Exclusion check

    The material is tested against the standing exclusions. Any match ends the review.

  3. 3

    Supplier qualification

    Manufacturer identity and documentation are confirmed before an order is placed.

  4. 4

    Batch analysis

    The first batch is held in quarantine and is released for sale only once its analytical certificate passes.

Standing exclusions.

If the legal status of a material changes in any destination served, the company’s documented service level is removal or restriction within 72 hours of confirmation.

No approved or branded human medicines
Materials are supplied as laboratory reference materials, never as finished medicinal products.
No prescription or controlled substances
In any market served.
No human-use claims, doses or protocols
No dosing guidance and no therapeutic positioning, anywhere.
No consumer-health positioning
Not presented for wellness or personal use.
No unrestricted destinations
Eligibility is set per material and per country; destination and sanctions screening precedes every dispatch.
No opaque ownership
One legal entity, one beneficial owner, publicly identified.

Ordering and dispatch.

Research-use statement
Present on every material page and label, and as a site-wide notice.
Logged research-use declaration
Declaration at order with timestamp and order reference retained.
Age and purpose confirmation
Purchasers separately confirm age of majority and a professional or research purpose.
Destination and sanctions screening
Applied before the dispatch of every order, on top of per-material, per-country eligibility.
Tracked fulfilment
Orders are tracked end to end through the logistics provider and proof of delivery is retained.

Quality assurance.

Material quality is verified independently of Atrio Sciences, not self-certified. Each batch is intended to be tested by an independent EU analytical laboratory before release, and the analytical certificate made available for the batch supplied.

A batch is held in quarantine from receipt until its certificate passes; nothing in quarantine is available for sale. A failed batch is removed from saleable stock. Every unit is labelled with the research-use statement, a batch identifier and storage conditions.

Suppliers are qualified before the first order, and the company maintains alternative sources for each material.

Ownership, records and accuracy.

Accurate representation
The company describes its activities and status as they are. Statements about legal status, testing, certification or partnerships must be capable of documentary verification.
Transparent ownership
One entity, one beneficial owner, publicly identified. Corporate documentation is available to counterparties and authorities on request.
Record retention
Corporate, supplier, product, order and compliance records are retained for the periods required by law and for audit.

Questions about how we work?

We answer regulatory and documentation questions directly. Write to info@atriosciences.com.